BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Sullivan SE. Endocannabinoids and the Cardiovascular System in Health and Disease. Handb Exp Pharmacol 2015;231:393-422. [PMID: 26408169 DOI: 10.1007/978-3-319-20825-1_14] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Karpińska O, Baranowska-Kuczko M, Kloza M, Ambroz Ewicz E, Kozłowski T, Kasacka I, Malinowska B, Kozłowska H. Activation of CB1 receptors by 2-arachidonoylglycerol attenuates vasoconstriction induced by U46619 and angiotensin II in human and rat pulmonary arteries. Am J Physiol Regul Integr Comp Physiol 2017;312:R883-93. [PMID: 28356298 DOI: 10.1152/ajpregu.00324.2016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
2 Ho WSV, Kelly MEM. Cannabinoids in the Cardiovascular System. Adv Pharmacol 2017;80:329-66. [PMID: 28826540 DOI: 10.1016/bs.apha.2017.05.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
3 Li Q, Garry MG. A murine model of the exercise pressor reflex. J Physiol 2020;598:3155-71. [PMID: 32406099 DOI: 10.1113/JP277602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Leo LM, Abood ME. CB1 Cannabinoid Receptor Signaling and Biased Signaling. Molecules 2021;26:5413. [PMID: 34500853 DOI: 10.3390/molecules26175413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Toczek M, Harasim E, Kasacka I, Malinowska B. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats. Life Sci 2016;151:288-99. [PMID: 26969765 DOI: 10.1016/j.lfs.2016.03.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
6 Lamani M, Malamas MS, Farah SI, Shukla VG, Almeida MF, Weerts CM, Anderson J, Wood JT, Farizatto KLG, Bahr BA, Makriyannis A. Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology. Bioorg Med Chem 2019;27:115096. [PMID: 31629610 DOI: 10.1016/j.bmc.2019.115096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Pędzińska-Betiuk A, Weresa J, Toczek M, Baranowska-Kuczko M, Kasacka I, Harasim-Symbor E, Malinowska B. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats. Br J Pharmacol 2017;174:2114-29. [PMID: 28437860 DOI: 10.1111/bph.13830] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
8 Cucchi D, Camacho-Muñoz D, Certo M, Niven J, Smith J, Nicolaou A, Mauro C. Omega-3 polyunsaturated fatty acids impinge on CD4+ T cell motility and adipose tissue distribution via direct and lipid mediator-dependent effects. Cardiovasc Res 2020;116:1006-20. [PMID: 31399738 DOI: 10.1093/cvr/cvz208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
9 Sharkey KA, Wiley JW. The Role of the Endocannabinoid System in the Brain-Gut Axis. Gastroenterology. 2016;151:252-266. [PMID: 27133395 DOI: 10.1053/j.gastro.2016.04.015] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 13.5] [Reference Citation Analysis]
10 Valencia-Guzmán CJ, Castro-Ruiz JE, García-Gasca T, Rojas-Molina A, Romo-Mancillas A, Luna-Vázquez FJ, Rojas-Molina JI, Ibarra-Alvarado C. Endothelial TRP channels and cannabinoid receptors are involved in affinin-induced vasodilation. Fitoterapia 2021;153:104985. [PMID: 34237389 DOI: 10.1016/j.fitote.2021.104985] [Reference Citation Analysis]
11 Malinowska B, Toczek M, Pędzińska-Betiuk A, Schlicker E. Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance. Br J Pharmacol 2019;176:1395-411. [PMID: 29455452 DOI: 10.1111/bph.14168] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
12 Musetti B, González-Ramos H, González M, Bahnson EM, Varela J, Thomson L. Cannabis sativa extracts protect LDL from Cu2+-mediated oxidation. J Cannabis Res 2020;2:37. [PMID: 33123676 DOI: 10.1186/s42238-020-00042-0] [Reference Citation Analysis]
13 Szabó R, Börzsei D, Szabó Z, Hoffmann A, Zupkó I, Priksz D, Kupai K, Varga C, Pósa A. A Potential Involvement of Anandamide in the Modulation of HO/NOS Systems: Women, Menopause, and "Medical Cannabinoids". Int J Mol Sci 2020;21:E8801. [PMID: 33233803 DOI: 10.3390/ijms21228801] [Reference Citation Analysis]
14 Sun HJ, Lu Y, Wang HW, Zhang H, Wang SR, Xu WY, Fu HL, Yao XY, Yang F, Yuan HB. Activation of Endocannabinoid Receptor 2 as a Mechanism of Propofol Pretreatment-Induced Cardioprotection against Ischemia-Reperfusion Injury in Rats. Oxid Med Cell Longev 2017;2017:2186383. [PMID: 28814985 DOI: 10.1155/2017/2186383] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
15 Szekeres M, Nádasy GL, Soltész-Katona E, Hunyady L. Control of myogenic tone and agonist induced contraction of intramural coronary resistance arterioles by cannabinoid type 1 receptors and endocannabinoids. Prostaglandins Other Lipid Mediat 2018;134:77-83. [PMID: 29031792 DOI: 10.1016/j.prostaglandins.2017.10.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
16 Li L, Dong X, Tu C, Li X, Peng Z, Zhou Y, Zhang D, Jiang J, Burke A, Zhao Z, Jin L, Jiang Y. Opposite effects of cannabinoid CB1 and CB2 receptors on antipsychotic clozapine-induced cardiotoxicity. Br J Pharmacol 2019;176:890-905. [PMID: 30707759 DOI: 10.1111/bph.14591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
17 Le Boisselier R, Alexandre J, Lelong-Boulouard V, Debruyne D. Focus on cannabinoids and synthetic cannabinoids. Clin Pharmacol Ther 2017;101:220-9. [PMID: 27861784 DOI: 10.1002/cpt.563] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 8.2] [Reference Citation Analysis]
18 Willis MS, Ilaiwy A, Montgomery MD, Simpson PC, Jensen BC. The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo. Metabolomics 2016;12:155. [PMID: 28533737 DOI: 10.1007/s11306-016-1097-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
19 Martínez-Aguirre C, Cinar R, Rocha L. Targeting Endocannabinoid System in Epilepsy: For Good or for Bad. Neuroscience 2021:S0306-4522(21)00637-0. [PMID: 34923038 DOI: 10.1016/j.neuroscience.2021.12.013] [Reference Citation Analysis]
20 Hu B, Bai F, Xiong L, Wang Q. The endocannabinoid system, a novel and key participant in acupuncture's multiple beneficial effects. Neurosci Biobehav Rev 2017;77:340-57. [PMID: 28412017 DOI: 10.1016/j.neubiorev.2017.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
21 van Esbroeck ACM, Varga ZV, Di X, van Rooden EJ, Tóth VE, Onódi Z, Kuśmierczyk M, Leszek P, Ferdinandy P, Hankemeier T, van der Stelt M, Pacher P. Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system. Pharmacol Res 2020;151:104578. [PMID: 31794870 DOI: 10.1016/j.phrs.2019.104578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]